BLUE,BLE | Zacks: Analysts Anticipate bluebird bio, Inc. (NASDAQ:BLUE) Will Announce Earnings of -$3.09 Per Share

Wall Street brokerages expect that bluebird bio, Inc.(NASDAQ:BLUE) will report ($3.09) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports.Nine analysts have provided estimates for bluebird bio’s earnings, with the lowest EPS estimate coming in at ($3.81) and the highest estimate coming in at ($0.98).bluebird bio reported earnings […]Stock Observer

BLUE,BLE | bluebird bio (NASDAQ:BLUE) Now Covered by Mizuho

Mizuho began coverage on shares of bluebird bio (NASDAQ:BLUE) in a report released on Monday, AR Network reports.The brokerage set a “buy” rating and a $123.00 price target on the biotechnology company’s stock.Mizuho’s price objective would suggest a potential upside of 123.64% from the stock’s current price.Several other analysts also recently weighed […]Zolmax News